International Patent: BRAIN-TARGETED AMYLOID BETA BINDING PROTEINS

GENEVA, Oct. 5 -- PARAGON THERAPEUTICS, INC. filed a patent application (US2026/020561) for “BRAIN-TARGETED AMYLOID BETA BINDING PROTEINS”. With publication no. WO/2026/206960, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07K 16/28

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....